Blueprint Medicines Corp
NASDAQ:BPMC 4:00:00 PM EDT
| Market Cap (Intraday) | 5.74B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $88.64 |
| 50-Day MA | $90.81 |
| 200-Day MA | $94.82 |
Blueprint Medicines Corp Stock, NASDAQ:BPMC
45 Sidney Street, 45 Sidney Street, Cambridge, Massachusetts 02139
United States of America
Phone: +1.617.374.7580
Number of Employees: 655
Description
Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.